13F Data
13F filer · CIK 1536054

Crestline Management, L.P.

FORT WORTH, TX · filing since Q4 2014 · last filing Aug 14, 2026
Reported value
$53.5M
+$7.2M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $7.7M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedDENALI THERAPEUTICS INC-300,000-13.6%$-7.7M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $1.4BQ1 2015: $1.6BQ2 2015: $1.4BQ3 2015: $1.1BQ4 2015: $1.1BQ1 2016: $653.9MQ2 2016: $666.9MQ3 2016: $788.7MQ4 2016: $400.7MQ1 2017: $546.5MQ2 2017: $746.5MQ3 2017: $719.4MQ4 2017: $976.2MQ1 2018: $803.8MQ2 2018: $951.7MQ3 2018: $1.1BQ4 2018: $661.3MQ1 2019: $461.1MQ2 2019: $742.6MQ3 2019: $620.9MQ4 2019: $772.3MQ1 2020: $347.5MQ2 2020: $545.6MQ3 2020: $678.3MQ4 2020: $943.0MQ1 2021: $787.5MQ2 2021: $1.2BQ3 2021: $1.1BQ4 2021: $1.3BQ1 2022: $834.0MQ2 2022: $766.4MQ3 2022: $739.8MQ4 2022: $682.4MQ1 2023: $842.1MQ2 2023: $957.6MQ3 2023: $858.4MQ4 2023: $1.2BQ1 2024: $1.1BQ2 2024: $1.3BQ3 2024: $1.9BQ4 2024: $3.0BQ1 2025: $63.2MQ2 2025: $62.6MQ3 2025: $58.1MQ4 2025: $53.3MQ1 2026: $46.3MQ2 2026: $53.5M
Q4 2014Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1DENALI THERAPEUTICS INCCOM1,910,732$49.1M91.90%
2SANA BIOTECHNOLOGY INCCOM755,736$2.6M4.93%
38X8 INC NEWCOM990,850$1.7M3.17%